Close

Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); 2012: Focus on Guidance, Cash Deployment. & Valuation Dec 19, 2011 08:45AM
Canaccord Genuity Generic Sector Revisit - Focus on Path Ahead of Several Near-term Catalysts Dec 8, 2011 11:12AM
Canaccord Genuity on Specialty Pharmaceuticals: Gx Lipitor - Broad Implications but Focus on Expectations Nov 28, 2011 09:18AM
Canaccord Genuity on Specialty Pharmaceuticals: Top Catalyst-Driven Stocks with Potential for Upside by Year-End Nov 15, 2011 09:21AM
Canaccord Genuity Reaffirms a 'Buy' on Teva Pharma (TEVA); Quantifying the "Inflection" Point From Here - Attractive Path Nov 7, 2011 09:16AM


Nov 3, 2011 10:15AM Canaccord Genuity Reaffirms a 'Buy' on Teva Pharma (TEVA); Improved visibility, Reset EPS and Catalyst Ahead
Oct 25, 2011 08:24AM Canaccord Genuity Reiterates a 'Buy' on Momenta (MNTA); Lovenox Authorized Generic Launched
Oct 24, 2011 10:47AM Notable Analyst Rating Changes 10/24: (BHP) (XL) (USU) Upgraded; (WEN) (IFF) (TEVA) Downgraded
Oct 24, 2011 08:51AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); View Post MNTA Management Meeting
Oct 24, 2011 08:39AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Amphastar/WPI Generic Enox TRO Extended, Injunction Ruling Delayed
Oct 12, 2011 08:55AM Canaccord Genuity Life Sciences/Specialty Pharmaceuticals: Three Catalysts With Potential To Drive Upside by Year-End - TEVA, WCRX & WPI
Oct 6, 2011 08:35AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Catalysts Ahead
Oct 3, 2011 08:39AM Canaccord Genuity Maintains a 'Buy' on Watson Pharmaceuticals (WPI); PROCHIEVE Survey Supports Above-consensus View
Sep 28, 2011 10:54AM Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Bottom-Up Approach to Volatile Sector - Initiating Coverage on Seven Stocks
Sep 28, 2011 08:30AM Canaccord Genuity Starts Teva Pharma (TEVA) at Buy; Accumulate Shares Ahead of 2012 Inflection Point
Sep 9, 2011 09:09AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Generic Copaxone Trial -- Day 2
Jul 12, 2011 08:19AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Case on Inequitable Conduct Credible, but Legal Hurdle Still High
May 6, 2011 11:48AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Strong M-enox Sales Continue
May 3, 2011 11:21AM Canaccord Genuity Maintains a 'Buy' on Valeant Pharmaceuticals (VRX); Withdraws Bid After Teva Makes Better Offer for Cephalon
Feb 11, 2011 01:25PM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Q4/10: M356 Trial Next Moves in H2/11, M-Enox Sales Steady Out
Feb 9, 2011 11:14AM Canaccord Genuity Morning Coffee on Teva Pharma (TEVA): Well, At Least It’s Not In Egypt.
Jan 24, 2011 11:42AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Mylan Copaxone Markman, Gad Patent Update: No Surprises
Dec 3, 2010 01:56PM Canaccord Genuity reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Fencing Off m-enox: MNTA Files Infringement Suit Against Teva
Nov 2, 2010 03:30PM Canaccord Genuity Morning Coffee on Avanir Pharma (AVNR): Approved – Game On!
Oct 6, 2010 11:49AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Have Increased Conviction M356